This subproject is one of many research subprojects utilizing the resources provided by a Center grant funded by NIH/NCRR. The subproject and investigator (PI) may have received primary funding from another NIH source, and thus could be represented in other CRISP entries. The institution listed is for the Center, which is not necessarily the institution for the investigator. The purpose of this research study is to determine the safety and possible benefit of using high dose VSL #3 in patients with active symptoms of mild to moderate ulcerative colitis.
Showing the most recent 10 out of 782 publications